zoledronic acid has been researched along with Femoral Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allen, MJ; Arrington, SA; Fisher, ER; Mann, KA; Willick, GE | 1 |
| Allen, MJ; Arrington, SA; Damron, TA; Mann, KA | 1 |
2 other study(ies) available for zoledronic acid and Femoral Neoplasms
| Article | Year |
|---|---|
Anabolic and antiresorptive drugs improve trabecular microarchitecture and reduce fracture risk following radiation therapy.
Topics: Anabolic Agents; Animals; Bone and Bones; Bone Density; Bone Density Conservation Agents; Carcinoma; Diphosphonates; Drug Therapy, Combination; Female; Femoral Neoplasms; Imidazoles; Mice; Mice, Nude; Osteolysis; Parathyroid Hormone; Zoledronic Acid | 2010 |
Concurrent administration of zoledronic acid and irradiation leads to improved bone density, biomechanical strength, and microarchitecture in a mouse model of tumor-induced osteolysis.
Topics: Animals; Bone Density; Bone Density Conservation Agents; Carcinoma; Chemotherapy, Adjuvant; Diphosphonates; Disease Models, Animal; Female; Femoral Neoplasms; Imidazoles; Mice; Osteolysis; Tensile Strength; Tumor Burden; Zoledronic Acid | 2008 |